Pricing Log in Create free account

Kairos Pharma, Ltd. (KAPA) vs Purple Biotech Ltd. Sponsored ADR (PPBT)

Kairos Pharma, Ltd. and Purple Biotech Ltd. Sponsored ADR are both Biotechnology companies. Kairos Pharma, Ltd. is the larger, with a market value of $2.3M against $2.0M — 1.1× the size. Across the 10 metrics below, Purple Biotech Ltd. Sponsored ADR leads on 6 and Kairos Pharma, Ltd. on 4.

Valuation

Metric KAPA PPBT Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.44 0.10 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.14 0.16 0.64
EV/Sales n/m n/m 9.21
Earnings yield (326.58%) (4,315.08%) (33.15%)
Free cash flow yield (216.16%) (643.44%) (25.50%)

Profitability

Metric KAPA PPBT Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (113.96%) (110.67%) (56.36%)
Return on assets (104.32%) (100.91%) (48.04%)
Return on invested capital (322.91%) (290.25%) 0.00%

Growth

Metric KAPA PPBT Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (30.44%) (10.14%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric KAPA PPBT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.98 3.70 4.72
Net debt to EBITDA 1.65 0.35 0.96

Dividend

Metric KAPA PPBT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KAPA PPBT Biotechnology median
Market cap 2.27m 1.99m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack